Paul Woolman is an equity product specialist with over 20 years markets experience. Paul joined CME Group in 2016 as Senior Director, Head of EMEA Equity and Alternative Index Products. This involves managing the associated futures and options product suite and working with clients to help educate them and work on product solutions. Before joining CME Group, Paul was at BAML for over 10 years as a Delta 1 equity trader – managing exposure across futures, ETFs, swaps, structured products as well as cash equities and FX. This has provided him with a wealth of experience in the pricing, trading, structuring and risk management of equity index-based derivative products. Paul has an MBA from London Business School with a concentration in Finance and has previous experience of emerging market cash equity trading and asset management.